Bioequivalence Study of Famitinib Malate in Healthy Volunteers Under Fasting Condition
Clinical trial NCT05336279 · COMPLETED
Trial details
- NCT number
- NCT05336279
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-11
- Primary completion
- 2022-05-27
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.